A PHASE 2 STUDY OF EVORPACEPT (ALX148) IN COMBINATION WITH PEMBROLIZUMAB AND CHEMOTHERAPY IN PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (HNSCC); ASPEN-04
JOURNAL FOR IMMUNOTHERAPY OF CANCER（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要